Mi SciELO
Servicios Personalizados
Articulo
Indicadores
- Citado por SciELO
Links relacionados
- Similares en SciELO
Compartir
Revista Cubana de Pediatría
versión On-line ISSN 1561-3119
Resumen
LORET DE MOLA BUENO, Yanet de los Ángeles; MUZIO GONZALEZ, Verena Lucila y HERNANDEZ-BERNAL, Francisco. Effectiveness and security of recombinant streptokinase in children with parapneumonic pleural efussion. Rev Cubana Pediatr [online]. 2020, vol.92, n.3 Epub 01-Sep-2020. ISSN 1561-3119.
Introduction:
The parapneumonic pleural efussion as a complication of pneumonias adquired in the community by the pediatric population represents a health problem in the world and in Cuba. The use of intrapleural fibrinolytics is a good therapeutic option.
Objective:
To evaluate the effectiveness and security of the use of recombinant streptokinase in the treatment of complex parapneumonic pleural efussion in children.
Methods:
Phase III confirmatory clinical trial, monocentric, open, randomized and controlled (RPCEC00000292) - named as DENIS study- carried out from September 2018 to October, 2019. There were included children (from 1 to 18 years old) that met the selection criteria including voluntariness. All of them received the established conventional treatment and were distributed in two groups: I- experimental (recombinant streptokinase, intrapleural daily dose of 200 000 UI, 3 - 5 days); II- control (conventional therapy). The main variables were need of surgery and hospital stay. There were also assessed the adverse events.
Results:
55 children with the above mentioned disease were assessed; 34 of them (61.8%) were included in the study. Any of the patients of the experimental group required surgery, opposite to the control group that required it in a 25%. The hospital stay was significantly reduced in the group that had treatment with recombinant streptokinase. There were not any severe adverse events related to the experimental treatment.
Conclusions:
When recombinant streptokinase was administered in the complex parapneumonic pleural efussion resulted in an efficient and safe method for the elimination of the septic focus, with a positive impact expressed in the reduction of complications, the need of surgical treatment and the hospital stay without presenting related adverse events while using it.
Palabras clave : parapneumonic pleural efussion; recombinant streptokinase; controlled clinical trial.